Transactions – Page 2

Sale of HealthGrid to AllScripts Healthcare Solutions

HealthGrid is a leader in the rapidly evolving healthcare patient engagement sector. Industry analyst KLAS defines patient engagement as “the process of motivating and enabling patients to participate in their own care with the expectation that, over time, outcomes will improve and costs will be reduced”. HealthGrid’s intelligent patient engagement technology platform enables providers to stay connected with their patients’ pre-care, point of care and post care, keeping them engaged, informed and supported throughout the healthcare continuum. Please refer to the Company’s website for …

Sale of Dynex Technologies to Telegraph Hill Partners

Dynex Technologies, headquartered in Chantilly, Virginia, with offices in Hong Kong, Germany and the U.K., pioneered microplate technology more than 60 years ago, and has since delivered a series of cutting edge, best-in-class ELISA processing systems, including the 4-plate DSX, 2-plate DS2 and Agility high throughput systems. Dynex designs each of its products to meet the rigorous demands of the clinical laboratory. Convergence was engaged by Dynex and its financial sponsors to pursue a strategic alternatives for Dynex including a sale of the Company. Convergence worked with management to …

Sale of Magellan Diagnostics to Meridian Bioscience

Magellan Diagnostics, Inc, headquartered in Billerica, MA pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. Convergence was engaged by Magellan and its financial sponsors, to pursue a sale of the Company. Convergence worked actively with Chairman Peter Glick and CEO Amy Winslow to craft a strategic marketing plan for the company that leveraged Magellan's historical performance as a market leader in Lead exposure testing while valuing the opportunity created by Magellan's next …

Sale of Lumora, Inc. to ERBA Diagnostics Mannheim

Lumora is a successful provider of state-of-the-art molecular diagnostic products into both the clinical and non-clinical or industrial markets. Lumora's technology is easy-to-deploy and use making it ideal to be deployed in fields as diverse as food safety testing, and medical diagnostics. The Company currently has products that are actively commercial has a number of leading development and commercialization partners include international biotechnology, clinical diagnostic and industrial microbiology companies Convergence had been engaged by Lumora’s Board of Directors to help the Company …

Lumora, Inc. Sale of Heat Elution Sample Prep Technology to Roche

Lumora is a UK-based leading developer of next-generation solutions in Molecular Diagnostics products and solutions. Lumora developed a highly differentiated proprietary methodology that will enable simple and automated nucleic acid isolation in minutes instead of hours called Heat Elution. The technology is environmentally friendly and can be applied to process a wide variety of sample types including whole blood, fecal matter, sputum, FFPE tissue and buccal swabs. Convergence had been engaged by Lumora’s Board of Directors to help the Company assess strategic alternatives for the Company. …

Sale of CECity.com, Inc. to Premier, Inc.

CECity.com, Inc., headquartered in Pittsburgh, PA, is a leading provider of cloud-based healthcare solutions, specializing in performance improvement, pay-for-value reporting and continuous professional education. CECity is a leading CMS qualified PQRS registry and powers approximately 20 percent of the nation’s Qualified Clinical Data Registries (QCDRs), which are aligned with PQRS, meaningful use and emerging payment models. CECity is the exclusive performance assessment organization for the Bridges to Excellence program. Our affiliate, Seven Hills Healthcare Advisors, advised CECity in …